Our Partners and recently joined Associated Members came together at the HARMONY General Assembly 2018, organized on 4 and 5 October in Valencia, Spain. The 3rd General Assembly was hosted by HULAFE, one of the 53 HARMONY Partners. Topics which were discussed: the HARMONY Data Platform and the HM (hematologic Malignancy) projects.
HARMONY Data Platform: Public repository datasets are uploaded from HM patients as a proof of concept. HARMONY uses state-of-the-art technologies to ensure the platform’s compliance with legal and ethical rules. HARMONY uses advanced big data technologies to enable stakeholders to share, connect, analyze, and interpret the data. For instance, we have recently implemented the so-called OMOP tool, which is a system to harmonize the data entrance in the platform by using the same units. This supporting big data infrastructure is unparalleled in the field of hematology. HARMONY is ready to transfer clinical trial datasets to the platform.
HM Projects: HARMONY focuses on the following seven hematologic malignancies (HMs): Acute lymphoblastic leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myelodysplastic Syndromes, Non-Hodgkins Lymphoma, Multiple Myeloma and Pediatric Hematologic Malignancies. At the General Assembly multiple HM projects were updated, discussed and further aligned.
Stay tuned for update articles.
Read and watch the HARMONY Alliance articles and interviews in the Spanish national press:
Receive the latest news. Click here to subscribe!